FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines

Transplant Proc. 2001 Nov-Dec;33(7-8):3057-63. doi: 10.1016/s0041-1345(01)02306-5.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Movement / drug effects
  • Cell Movement / physiology
  • Chemokines / immunology*
  • Fingolimod Hydrochloride
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Leukopenia / chemically induced
  • Lymphocytes / drug effects
  • Lymphocytes / physiology*
  • Lymphopenia / chemically induced
  • Mice
  • Phosphatidylinositol 3-Kinases / metabolism
  • Propylene Glycols / adverse effects
  • Propylene Glycols / therapeutic use*
  • Sphingosine / analogs & derivatives
  • Transplantation Immunology*

Substances

  • Chemokines
  • Immunosuppressive Agents
  • Propylene Glycols
  • Phosphatidylinositol 3-Kinases
  • Fingolimod Hydrochloride
  • Sphingosine